Regional anesthesia. Local anaesthetics
Conditions
Interventions
Intervention 1: Intervention:2 groups which one of them will take 3 mg/kg lidocaine 0.5% with 1 µg/kg dexmedetomidine dilutioned by saline0.9% to 40 cc.next group will take 3 mg/kg lidocaine 0.5% wit
Treatment - Drugs
Intervention:2 groups which one of them will take 3 mg/kg lidocaine 0.5% with 1 µg/kg dexmedetomidine dilutioned by saline0.9% to 40 cc.next group will take 3 mg/kg lidocaine 0.5% with 30mg ketrolac
control:these patients will take 3 mg/kg lidocaine 0.5% dilutioned by saline 0.9% to 40 cc in 90 seconds.
Sponsors
Arak University of Medical Sciences, Vice chancellor for research
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 20 to 50 years old; ASA I or II. Exclusion criteria: drug allergy history; history of cardiac disease; hypertension treated with methyl dopa and clonidine; bradycardia; pregnancy; hematologic disorders and coagulopathies; renal diseases; gastrointestinal bleeding; operation duration lesser than 40 and over 90 minutes; opiate or analgesic drugs history.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tourniquet pain. Timepoint: After injection then 15, 30 and 45 minute after injection. Method of measurement: VAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of pain. Timepoint: Every 30 minutes until 2 hours after removing tourniquet. Method of measurement: VAS.;Vital signs. Timepoint: After removing tourniquet. Method of measurement: Common ways.;O2 saturation. Timepoint: After removing tourniquet. Method of measurement: Pulse oxymeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHesameddin Modir
Vali-e-Asr hospital
Outcome results
None listed